Benitec Biopharma Inc. (BNTC)

Accolade Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	103.58	50.87	2.48	4.06	19.77	9.8
Short-Term Investments	-	-	-	-	-	0
Cash & Short-Term Investments	103.58	50.87	2.48	4.06	19.77	9.8
Cash Growth	632.40%	1953.53%	-39.02%	-79.45%	101.68%	-37.64%
Accounts Receivable	-	0.23	0.06	0	0.03	0.06
Other Receivables	0	-	-	-	-	-
Receivables	0	0.23	0.06	0	0.03	0.06
Prepaid Expenses	0.36	0.52	1.18	0.74	0.8	0.86
Restricted Cash	0.06	0.06	0.01	0.01	0.02	-
Other Current Assets	-	-	-	-	-	0.09
Total Current Assets	104.01	51.67	3.73	4.82	20.61	10.81
Property, Plant & Equipment	1.11	0.45	0.61	0.99	0.58	0.77
Other Long-Term Assets	0.09	0.09	0.12	0.16	0.19	0.01
Total Assets	105.21	52.21	4.46	5.97	21.38	11.59
Accounts Payable	0.43	1.35	1.14	0.42	0.27	0.28
Accrued Expenses	0.86	0.65	0.74	0.7	0.49	0.46
Current Portion of Leases	0.35	0.28	0.28	0.25	0.21	0.19
Other Current Liabilities	5.39	2.64	1.82	1.16	0.39	0.2
Total Current Liabilities	7.03	4.92	3.98	2.53	1.37	1.14
Long-Term Leases	0.61	-	0.28	0.56	-	0.21
Total Liabilities	7.64	4.96	4.26	3.09	1.37	1.35
Common Stock	0	0	-	-	0	-
Additional Paid-In Capital	310.31	238.4	168.92	152.45	151.58	128.83
Retained Earnings	-212.03	-190.26	-167.89	-148.33	-130.12	-116.64
Comprehensive Income & Other	-0.72	-0.89	-0.83	-1.25	-1.46	-1.95
Shareholders' Equity	97.57	47.25	0.2	2.88	20.01	10.24
Total Liabilities & Equity	105.21	52.21	4.46	5.97	21.38	11.59
Total Debt	0.96	0.28	0.56	0.81	0.21	0.41
Net Cash (Debt)	102.62	50.58	1.92	3.25	19.56	9.4
Net Cash Growth	644.25%	2537.23%	-41.00%	-83.38%	108.11%	-40.22%
Net Cash Per Share	5.68	12.46	1.38	6.76	77.40	156.43
Filing Date Shares Outstanding	25.6	10.56	2.55	0.48	0.48	0.07
Total Common Shares Outstanding	25.55	10.09	1.65	0.48	0.48	0.07
Working Capital	96.98	46.75	-0.25	2.29	19.24	9.67
Book Value Per Share	3.82	4.68	0.12	6.00	41.63	157.03
Tangible Book Value	97.57	47.25	0.2	2.88	20.01	10.24
Tangible Book Value Per Share	3.82	4.68	0.12	6.00	41.63	157.03
Machinery	1.57	1.55	1.38	1.37	1.36	1.14
Leasehold Improvements	0.02	0.02	0.02	0.02	0.02	0.02

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q